Meyka Pro banner
Penumbra, Inc.

Penumbra, Inc. (PEN) Stock Overview

Explore Penumbra, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PENNYSE
HealthcareMedical - Devices
$326.75
$0.17(0.05%)
U.S. Market opens in 3h 9m

Penumbra, Inc. (PEN)

Meyka AI Score

Z

Key Financials

Market Cap12.9B
P/E Ratio79.90
EPS (TTM)$3.83
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$360.88
3 Months$336.45
1 Year Target$301.36

PEN Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Penumbra, Inc. (NYSE: PEN) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Penumbra, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PEN on the NYSE shows an RSI of 72.53, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $301.36 for the NYSE listing.

Key metrics behind Penumbra, Inc.'s NYSE-traded stock include a P/E ratio of 79.90 and a market capitalization of 12.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PEN on the NYSE.

Price Performance (NYSE: PEN)

1-Day Change
0.11%
5-Day Change
0.62%
1-Month Change
2.51%
3-Month Change
1.35%
6-Month Change
-3.64%
Year-to-Date (YTD) Change
5.16%
1-Year Change
27.03%
3-Year Change
27.90%
5-Year Change
26.89%
All-Time (Max) Change
691.62%

Contact Information

510 748 3200
One Penumbra Place, Alameda, CA, 94502

Company Facts

47,000 Employees
IPO DateSep 18, 2015
CountryUS
Actively Trading

Frequently Asked Questions